Routine insider onboarding filing. No trading signal. Monitor for any future Form 4 filings that would indicate insider buying or selling activity.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.89entry
- T+1 · 6d ago −12.42%α −11.95% · $13.04
- T+5 · due 11h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Jeffrey L. Boerneke filed a Form 3 initial statement of beneficial ownership after becoming General Counsel and Secretary of Aspen Neuroscience. He reported an option to purchase 101,193 shares at $9.79, vesting over four years. This is a routine insider filing with no material price impact.
Key Facts
- Jeffrey L. Boerneke appointed General Counsel and Secretary of Aspen Neuroscience, Inc.
- Boerneke filed a Form 3 initial statement of beneficial ownership on 2026-10-29.
- Boerneke reported a stock option to buy 101,193 shares at $9.79 per share.
- Option granted on May 13, 2026, vesting 1/4 on May 7, 2027, then 1/48 monthly thereafter.
- Option expires on May 12, 2036.
Financial Impact
Option for 101,193 shares at $9.79 strike price; no immediate financial impact.
Risk Factors
- No material risk identified from this filing.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-439153 |
| Document: 0001193125-26-439153-index.html | 0001193125-26-439153 |
| Document: 0001193125-26-439153.txt | 0001193125-26-439153 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers